ANIP
ANI Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANIP fundamentals
ANI Pharmaceuticals (ANIP) released its earnings on Nov 7, 2025: revenue was 227.81M (YoY +53.58%), beat estimates; EPS was 2.04 (YoY +52.24%), beat estimates.
Revenue / YoY
227.81M
+53.58%
EPS / YoY
2.04
+52.24%
Report date
Nov 7, 2025
ANIP Earnings Call Summary for Q3,2025
- Record Growth: Q3 2025 revenue up 54% YoY, driven by 93.8% surge in Cortrophin Gel to $101.9M.
- Guidance Raise: 2025 net revenue target $854-873M (+39-42%), Cortrophin Gel forecast $347-352M (+75-78%).
- Generics Momentum: Low 20% growth for 2025, though Q4 may dip due to competitive pressure.
- ILUVIEN Reset: 2026 focus on Medicare access and new label adoption, with 10x addressable patient potential.
- Financial Strength: $262.6M cash, 1.7x net leverage, and 59.2% adjusted EBITDA margin.
EPS
Revenue
Revenue & Expenses
ANIP has released its 2025 Q3 earnings report, with revenue of 227.81M, reflecting a YoY change of 53.58%, and net profit of 26.62M, showing a YoY change of 210.14%. The Sankey diagram below clearly presents ANIP's revenue sources and cost distribution.
Key Indicators
ANI Pharmaceuticals (ANIP) key financial stats and ratios, covering profitability, financial health, and leverage.
ANI Pharmaceuticals (ANIP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ANI Pharmaceuticals (ANIP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ANI Pharmaceuticals (ANIP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ANI Pharmaceuticals (ANIP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ANI Pharmaceuticals (ANIP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is ANI Pharmaceuticals's latest dividend and current dividend yield?What guidance did ANI Pharmaceuticals's management provide for the next earnings period?What is the revenue and EPS growth rate for ANI Pharmaceuticals year over year?What were the key takeaways from ANI Pharmaceuticals’s earnings call?What does ANI Pharmaceuticals do and what are its main business segments?What were the key takeaways from ANI Pharmaceuticals's earnings call?What is the market's earnings forecast for ANI Pharmaceuticals next quarter?What factors drove the changes in ANI Pharmaceuticals's revenue and profit?
